KRAS and carcinoma: The absence of any lung defects in similar UPK II mouse models when urothelial proliferation and carcinoma are present (UPK II-SV40 mice) [17], also suggests that mutated K-ras expression, and not proliferation per se, leads to impaired lung development in this setting.